Citation 71897

HU,CQ: CHEN,K: SHI,Q: KILKUSKIE,RE: CHENG,YC: LEE,KH:. (1994). ANTI-AIDS AGENTS, 10. ACACETIN-7-O-BETA-D-GALACTOPYRANOSIDE, AN ANTI-HIV PRINCIPLE FROM CHRYSANTHEMUM MORIFOLIUM AND A STRUCTURE ACTIVITY CORRELATION WITH SOME RELATED FLAVONOIDS.. 57(1)

Citation Details

Title	ANTI-AIDS AGENTS, 10. ACACETIN-7-O-BETA-D-GALACTOPYRANOSIDE, AN ANTI-HIV PRINCIPLE FROM CHRYSANTHEMUM MORIFOLIUM AND A STRUCTURE ACTIVITY CORRELATION WITH SOME RELATED FLAVONOIDS.
Authors	HU,CQ: CHEN,K: SHI,Q: KILKUSKIE,RE: CHENG,YC: LEE,KH:
Year	1994
Volume	57
Issue	1

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
8	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	ACTIVE
10	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
14	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	WEAK ACTIVITY
16	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	ACTIVE
18	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
20	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
22	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-8-DIHYDROXY:	ACTIVE
24	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-8-DIHYDROXY:	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	ACTIVE
26	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	ACTIVE

Dendranthema morifolium (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACACETIN-7-O-BETA-D-GALACTOPYRANOSIDE	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN-7-O-BETA-D-GALACTOPYRANOSIDE	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN-7-O-BETA-D-GALACTOPYRANOSIDE	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	APIGENIN-7-O-BETA-D-GALACTOPYRANOSIDE	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN-7-O-BETA-D-GALACTOPYRANOSIDE	EQUIVOCAL
9	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN-7-O-BETA-D-GALACTOPYRANOSIDE	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	LUTEOLIN	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN	None
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	WEAK ACTIVITY
15	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
16	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ACACETIN-7-O-(6''-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN-7-O-(6''-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
18	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN-7-O-(6''-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
19	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	CYNAROSIDE	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAROSIDE	ACTIVE
21	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAROSIDE	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDQUANTITATIVE DATA	LUTEOLIN,4'-METHOXY: 7-O-BETA-D-GLUCOPYRANOSIDE	None
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,4'-METHOXY: 7-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
24	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,4'-METHOXY: 7-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BAICALIN	None
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALIN	ACTIVE
27	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALIN	ACTIVE